174 related articles for article (PubMed ID: 24669873)
1. Interaction between prion protein and Aβ amyloid fibrils revisited.
Nieznanski K; Surewicz K; Chen S; Nieznanska H; Surewicz WK
ACS Chem Neurosci; 2014 May; 5(5):340-5. PubMed ID: 24669873
[TBL] [Abstract][Full Text] [Related]
2. Soluble Prion Protein Binds Isolated Low Molecular Weight Amyloid-β Oligomers Causing Cytotoxicity Inhibition.
Williams TL; Choi JK; Surewicz K; Surewicz WK
ACS Chem Neurosci; 2015 Dec; 6(12):1972-80. PubMed ID: 26466138
[TBL] [Abstract][Full Text] [Related]
3. Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein.
Balducci C; Beeg M; Stravalaci M; Bastone A; Sclip A; Biasini E; Tapella L; Colombo L; Manzoni C; Borsello T; Chiesa R; Gobbi M; Salmona M; Forloni G
Proc Natl Acad Sci U S A; 2010 Feb; 107(5):2295-300. PubMed ID: 20133875
[TBL] [Abstract][Full Text] [Related]
4. Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role OF N-terminal residues.
Chen S; Yadav SP; Surewicz WK
J Biol Chem; 2010 Aug; 285(34):26377-83. PubMed ID: 20576610
[TBL] [Abstract][Full Text] [Related]
5. The anti-prion RNA aptamer R12 disrupts the Alzheimer's disease-related complex between prion and amyloid β.
Iida M; Mashima T; Yamaoki Y; So M; Nagata T; Katahira M
FEBS J; 2019 Jun; 286(12):2355-2365. PubMed ID: 30916478
[TBL] [Abstract][Full Text] [Related]
6. A d-enantiomeric peptide interferes with heteroassociation of amyloid-β oligomers and prion protein.
Rösener NS; Gremer L; Reinartz E; König A; Brener O; Heise H; Hoyer W; Neudecker P; Willbold D
J Biol Chem; 2018 Oct; 293(41):15748-15764. PubMed ID: 30131337
[TBL] [Abstract][Full Text] [Related]
7. Cellular prion protein and Alzheimer disease: link to oligomeric amyloid-β and neuronal cell death.
Kudo W; Petersen RB; Lee HG
Prion; 2013; 7(2):114-6. PubMed ID: 23154635
[TBL] [Abstract][Full Text] [Related]
8. Identification of PrP sequences essential for the interaction between the PrP polymers and Aβ peptide in a yeast-based assay.
Rubel AA; Ryzhova TA; Antonets KS; Chernoff YO; Galkin A
Prion; 2013; 7(6):469-76. PubMed ID: 24152606
[TBL] [Abstract][Full Text] [Related]
9. The pathogenesis of soluble PrP fragments containing Aβ binding sites.
Li B
Virus Res; 2016 Jan; 211():194-8. PubMed ID: 26528810
[TBL] [Abstract][Full Text] [Related]
10. Cellular prion protein targets amyloid-β fibril ends via its C-terminal domain to prevent elongation.
Bove-Fenderson E; Urano R; Straub JE; Harris DA
J Biol Chem; 2017 Oct; 292(41):16858-16871. PubMed ID: 28842494
[TBL] [Abstract][Full Text] [Related]
11. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.
Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M
Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981
[TBL] [Abstract][Full Text] [Related]
12. Amyloid-β-induced synapse damage is mediated via cross-linkage of cellular prion proteins.
Bate C; Williams A
J Biol Chem; 2011 Nov; 286(44):37955-37963. PubMed ID: 21900234
[TBL] [Abstract][Full Text] [Related]
13. Preferential Recruitment of Conformationally Distinct Amyloid-β Oligomers by the Intrinsically Disordered Region of the Human Prion Protein.
Madhu P; Mukhopadhyay S
ACS Chem Neurosci; 2020 Jan; 11(1):86-98. PubMed ID: 31808343
[TBL] [Abstract][Full Text] [Related]
14. Cellular prion protein is essential for oligomeric amyloid-β-induced neuronal cell death.
Kudo W; Lee HP; Zou WQ; Wang X; Perry G; Zhu X; Smith MA; Petersen RB; Lee HG
Hum Mol Genet; 2012 Mar; 21(5):1138-44. PubMed ID: 22100763
[TBL] [Abstract][Full Text] [Related]
15. Prion protein-mediated toxicity of amyloid-β oligomers requires lipid rafts and the transmembrane LRP1.
Rushworth JV; Griffiths HH; Watt NT; Hooper NM
J Biol Chem; 2013 Mar; 288(13):8935-51. PubMed ID: 23386614
[TBL] [Abstract][Full Text] [Related]
16. Amyloid-beta42 interacts mainly with insoluble prion protein in the Alzheimer brain.
Zou WQ; Xiao X; Yuan J; Puoti G; Fujioka H; Wang X; Richardson S; Zhou X; Zou R; Li S; Zhu X; McGeer PL; McGeehan J; Kneale G; Rincon-Limas DE; Fernandez-Funez P; Lee HG; Smith MA; Petersen RB; Guo JP
J Biol Chem; 2011 Apr; 286(17):15095-105. PubMed ID: 21393248
[TBL] [Abstract][Full Text] [Related]
17. Prion protein stabilizes amyloid-β (Aβ) oligomers and enhances Aβ neurotoxicity in a
Younan ND; Chen KF; Rose RS; Crowther DC; Viles JH
J Biol Chem; 2018 Aug; 293(34):13090-13099. PubMed ID: 29887525
[TBL] [Abstract][Full Text] [Related]
18. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
[TBL] [Abstract][Full Text] [Related]
19. Soluble prion protein inhibits amyloid-β (Aβ) fibrillization and toxicity.
Nieznanski K; Choi JK; Chen S; Surewicz K; Surewicz WK
J Biol Chem; 2012 Sep; 287(40):33104-8. PubMed ID: 22915585
[TBL] [Abstract][Full Text] [Related]
20. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.
Nussbaum JM; Schilling S; Cynis H; Silva A; Swanson E; Wangsanut T; Tayler K; Wiltgen B; Hatami A; Rönicke R; Reymann K; Hutter-Paier B; Alexandru A; Jagla W; Graubner S; Glabe CG; Demuth HU; Bloom GS
Nature; 2012 May; 485(7400):651-5. PubMed ID: 22660329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]